- Latest week
- 17 Jul 2026
- Close
- 240.000000
- Fair value
- 164.761947
- Next-week expectancy
- Positive 55.88%
ALK-B Chart Pack
ALK-Abelló A/S
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, ALK-B fell 0.83%, moving from 242.00 to 240.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 0.03 and has softened across the 12-week window. Market Dynamics is 0.03 on the latest week. Next-week expectancy is positive at 55.88% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 240.00
- 12-Week Change
- -0.83%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 55.88%
- Signal Weeks
- 11 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 0.03
- Market Dynamics
- 0.03
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 240.00
- 12-Week Change
- -0.83%
- Trend Signal
- Active
- Next-Week Expectancy
- Positive 55.88%
- Signal Weeks
- 11 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 0.03
- Market Dynamics
- 0.03
Over the latest 12 completed weeks ending 2026-07-17, ALK-B fell 0.83%, moving from 242.00 to 240.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 11 of the last 12 weeks. Relative Strength is 0.03 and has softened across the 12-week window. Market Dynamics is 0.03 on the latest week. Next-week expectancy is positive at 55.88% based on similar historical setup states.
Industry Peers
Denmark equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| STRAP Strategic Partners A/S | CPH | 17 Jul 2026 | 575.00 | 640.00 | 560.00 | 640.00 | 11.30% |
| PEG Pharma Equity Group A/S | CPH | 17 Jul 2026 | 0.08 | 0.09 | 0.08 | 0.09 | 8.86% |
| ZEAL Zealand Pharma A/S | CPH | 17 Jul 2026 | 282.00 | 304.40 | 268.90 | 295.40 | 4.75% |
| BAVA Bavarian Nordic A/S | CPH | 17 Jul 2026 | 183.10 | 187.50 | 179.50 | 184.10 | 0.55% |
| GMAB Genmab A/S | CPH | 17 Jul 2026 | 1879.50 | 1907.00 | 1840.00 | 1869.00 | -0.56% |
| GUBRA Gubra A/S | CPH | 17 Jul 2026 | 355.60 | 364.80 | 328.80 | 342.00 | -3.82% |